Feng Zhang

Feng Zhang

Auto-generated profile, based on publicly available information

Feng Zhang

Department of Emergency, Jinshan Hospital Affiliated to Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
YLYUJUAN LIU
YUJUAN LIU
XZXian Zhu
Xian Zhu
RLRongxin Li
Rongxin Li
JZJun Zhang
Jun Zhang
FZFeng Zhang
Feng Zhang
Objectives This study aimed to characterise the prescribing patterns and evaluate the appropriateness of the prescribed proton pump inhibitors (PPIs) in adult patients via a review of electronic medical records in a single-centred hospital. Design All patients admitted to the outpatient department of Jinshan Hospital, Fudan University, Shanghai, between 1 January 2018 and 31 December 2018 were evaluated. Individuals aged 18 years or above and with at least one dispensing for PPIs were identified as PPI users. New PPI users were defined as a subject who did not receive any dispensing for PPIs in the year prior to the index date. Baseline characteristics of PPI users and their therapies were described by treatment indication, economic indicators and co-prescription, overall and separately. Setting The prescription database was retrieved from the hospital information system of Jinshan Hospital, Fudan University. Results Among 18 435 identified PPI users in 2018, 14 219 patients (aged 18 years or above) who had at least one dispensing PPIs were new users (77%), and among them, men accounted for 47%. The mean treatment duration was 23 days. Omeprazole was the most commonly prescribed drug. PPIs are inappropriately prescribed in 50% (13 589/25 850) of prescriptions. Prescription appropriateness analysis indicated that the unapproved indications for PPI new users accounted for 47%; among them, the proportion of gastritis diagnosis was 34%. The proportion of PPI new users with co-prescription of glucocorticosteroids (GCs) who have risk factors accounted for 24% and lower than other co-prescription. A majority of PPI users (73%) reported high-dose PPI prescription. The defined daily dose of oral pantoprazole was the highest, and injectable omeprazole had the highest defined daily cost. In contrast, only the drug utilisation index value of oral esomeprazole was less than 1.0. Conclusion The results indicate the challenge of PPI use was accompanied by unapproved indications, frequent inappropriate co-prescription with GCs and excessive dosages. Efforts should be paid to promote rational use and ensure the choice of suitable PPI therapy in the future.

15 October 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YLYujuan Liu
Yujuan Liu
WRWeifang Ren
Weifang Ren
SWShuying Wang
Shuying Wang
MXMinmin Xiang
Minmin Xiang
SZShun-Xian Zhang
Shun-Xian Zhang
FZFeng Zhang
Feng Zhang
Background: Anemia represents a significant global health issue affecting numerous children and women, characterized by diminished hemoglobin levels that may impede cognitive and developmental progress. Although commonly attributed to iron deficiency, the etiology of anemia in this demographic is multifaceted, encompassing nutritional, genetic, and infectious contributors. Nonetheless, there is a lack of high-quality data on anemia prevalence and causes analysis among children under 5 years. The aim of this study was to provide a comprehensive global assessment of the burden of anemia and its causes among children under 5 years, using data from the Global Burden of Disease Study 2019.Methods: This investigation utilized data from the Global Burden of Disease Study (GBD) 2019 to assess the prevalence and years lived with disability (YLD) attributable to anemia in children under five from 1990 to 2019. Analyses were conducted to delineate age-specific YLD, prevalence rates, and etiological factors, with stratification by gender and Socio-Demographic Index (SDI).Results: In 2019, anemia imposed a substantial global burden on children under five, with a reported YLD of 1,252.88 (95% UI: 831.62–1,831.34) per 100,000 population. The prevalence of moderate anemia was highest at 985.46 (95% UI: 646.24–1,450.49) per 100,000, surpassing both severe anemia at 197.82 (95% UI: 132.53–277.80) per 100,000 and mild anemia at 69.59 (95% UI: 24.62–152.53) per 100,000. Globally, the total prevalence was 39,517.75 (95% UI: 38,784.81 - 40,239.62) cases per 100,000 population. Notably, disparities were evident between genders, with males demonstrating higher YLD and prevalence rates than females. Iron deficiency emerged as the leading cause globally, with significant contributions from hemoglobinopathies and other nutritional deficiencies. Regions with a low Socio-Demographic Index, particularly sub-Saharan Africa and South Asia, exhibited the most pronounced burdens. Despite a declining trend over three decades, persistent regional and gender-based disparities highlight the necessity for continuous and focused public health interventions.Conclusion: The burden of anemia among children under five continues to be considerable, marked by stark regional and socioeconomic disparities. These findings underscore the urgent need for advanced nutritional and healthcare strategies tailored to alleviate anemia in this vulnerable population, with a particular emphasis on regions exhibiting low SDIs. The sustained prevalence of high anemia rates in these areas underscores the imperative for persistent, localized intervention efforts.

1 April 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XWXi Wang
Xi Wang
YXYanyan Xing
Yanyan Xing
ZTZhongyan Tang
Zhongyan Tang
YTYuedong Tang
Yuedong Tang
JSJie Shen
Jie Shen
FZFeng Zhang
Feng Zhang

1 January 2018 in Fitoterapia
Verified
Journal Article
Closed access
ZTZhongyan Tang
Zhongyan Tang
JSJunmei Shen
Junmei Shen
FZFeng Zhang
Feng Zhang
JLJingyu Liang
Jingyu Liang
ZXZhengxiang Xia
Zhengxiang Xia

27 November 2023 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
JZJia‐Xi Zhu
Jia‐Xi Zhu
YDYu Dun
Yu Dun
WWWei Wu
Wei Wu
JSJie Shen
Jie Shen
FZFeng Zhang
Feng Zhang
LZLin Zhang
Lin Zhang
Intestinal ischemia/reperfusion (I/R) injury is a life‐threatening condition with no effective treatment currently available. Curcumin (CCM), a polyphenol compound in Curcuma Longa, reportedly has positive effects against intestinal I/R injury. However, the mechanism underlying the protective effect of CCM against intestinal I/R injury has not been fully clarified. To determine whether the protective effect of CCM was mediated by epigenetic effects on Wnt/β‐catenin signaling, the effect of CCM was examined in vivo and in vitro. An intestinal I/R model was established in Sprague–Dawley (SD) rats with superior mesenteric artery occlusion, and Caco‐2 cells were subjected to hypoxia/reoxygenation (H/R) for in vivo simulation of I/R. The results showed that CCM significantly reduced inflammatory, cell apoptosis, and oxidative stress induced by I/R insult in vivo and in vitro. Western blot analysis showed that CCM preconditioning reduced the protein levels of β‐catenin, p‐GSK3β, and cyclin‐D1 and increased the protein level of GSK3β compared with the I/R group. Overexpressing β‐catenin aggravated H/R injury, and knocking down β‐catenin relieved H/R injury by improving intestinal permeability and reducing the cell apoptosis. Moreover, Naked cuticle homolog 2(NKD2) mRNA and protein levels were upregulated in the CCM‐pretreated group. 5‐aza‐2′‐deoxycytidine (5‐AZA) treatment improved intestinal epithelial barrier impairment induced by H/R. Besides, the protein levels of total β‐catenin, phosphor‐β‐catenin and cyclin‐D1 were reduced after overexpressing NKD2 in Caco‐2 cells following H/R insult. In conclusion, Our study suggests that CCM could attenuate intestinal I/R injury in vitro and in vivo by suppressing the Wnt/β‐catenin signaling pathway via inhibition of NKD2 methylation.

8 December 2018 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
XJX. Jia
X. Jia
TZT. Zhai
T. Zhai
BWB. Wang
B. Wang
JZJinan Zhang
Jinan Zhang
FZF. Zhang
F. Zhang